An Open Access Journal from Taylor & Francis
As a Q1-ranked journal, Virulence is one of the top journals globally with a unique focus on pathogenicity and pathogenesis.
Virulence is the first international peer-reviewed journal of its kind with a specific focus on microbial pathogenicity, the infection process and host-pathogen interactions, including the interaction between host and environment.
To address the new infectious challenges, emerging infectious agents and antimicrobial resistance, there is a clear need for interdisciplinary research. As a multidisciplinary journal, Virulence brings together scientists and clinical researchers working on the 'pathogen,' the 'host' or the 'antimicrobial agents.' It is particularly interested in infection models and actual infections, in the mechanisms, severity and attenuation of infection. As a fully open access journal all articles are available for anyone to read anywhere, at any time, immediately on publication.
Virulence publishes Special Issues on a range of topics. Explore Special Issues.
2020 Impact Factor 5.882
Five-Year Impact Factor 6.489
-Journal Citation Reports®
WEB OF SCIENCE, MEDLINE and PUBMED CENTRAL Indexed
2020 CiteScore 9.0
Virulence is particularly interested in receiving manuscripts on:
- Microbial pathogenicity–viruses (including HIV), bacteria, fungi, and parasites
- Molecular and biological function of established and novel virulence factors
- Identification, development and study of antimicrobial agents
- Host-pathogen and pathogen-pathogen interactions
- Host response to infection and immune responses to inhibitors, toxins, and other virulence factors
- Mammalian, other vertebrate as well as invertebrate model organisms and hosts
- Clinical trials evaluating all aspects of the infection process
- Research on bio-terrorism agents
- Vaccine development and evaluation
- Diagnosis of infectious diseases
- Infections in resource-limited settings
Virulence is officially affiliated with the American Society for Virology, and ASV members can benefit from a discounted APC.
Meet the Editor-in-Chief
Follow Kevin on Twitter @KevinMTyler
Dr. Kevin Tyler runs a cosmopolitan, multidisciplinary group taking a genomics led approach to tackling problems associated with a variety of (water borne and vector borne) microbial diseases supported by grants from the Wellcome Trust, the European Commission (Framework VI, VII, Horizon 2020 and Interreg) and the British Council for networks of research and collaboration across Europe, South America and Africa. He has served as an NTD expert to the European Commission and is an advocate for solutions to these diseases through his current role as the general secretary of the British Society for Parasitology.
His interest is focused at achieving an understanding of pathogen virulence - how and why new virulent lineages emerge and why some are profoundly affected by an infection which can be asymptomatic in others. His approach has been to utilize discoveries of specific pathogen biology and genetics from his laboratory to inform innovation and validation of novel diagnostics and therapeutics and public health approaches to tackling the diseases.
He has also been a proponent and pioneer of Open Access Publication and is a modernizer of effective communication and publication for research in communicable disease to enable access of the key scientific literature by scientists and clinicians in the more impoverished countries most affected by infectious disease.
We recently conducted an interview with Kevin on Twitter to ask his views on the challenges facing the research community and the benefits of publishing open access.